Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Short-Term Debt issuances (2016 - 2022)

Prestige Consumer Healthcare has reported Short-Term Debt issuances over the past 11 years, most recently at $20.0 million for Q2 2022.

  • Quarterly results put Short-Term Debt issuances at $20.0 million for Q2 2022, down 76.47% from a year ago — trailing twelve months through Mar 2023 was $20.0 million (down 76.47% YoY), and the annual figure for FY2023 was $20.0 million, down 76.47%.
  • Short-Term Debt issuances for Q2 2022 was $20.0 million at Prestige Consumer Healthcare, down from $85.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for PBH hit a ceiling of $85.0 million in Q2 2021 and a floor of $10.0 million in Q1 2018.
  • Median Short-Term Debt issuances over the past 5 years was $15.0 million (2018), compared with a mean of $25.0 million.
  • Biggest five-year swings in Short-Term Debt issuances: plummeted 88.89% in 2018 and later soared 50.0% in 2019.
  • Prestige Consumer Healthcare's Short-Term Debt issuances stood at $15.0 million in 2018, then changed by 0.0% to $15.0 million in 2019, then changed by 0.0% to $15.0 million in 2020, then skyrocketed by 466.67% to $85.0 million in 2021, then tumbled by 76.47% to $20.0 million in 2022.
  • The last three reported values for Short-Term Debt issuances were $20.0 million (Q2 2022), $85.0 million (Q2 2021), and $15.0 million (Q4 2020) per Business Quant data.